NATHALIE COHENCA: Open Payments
NPI 1144894858 · KIRKLAND, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,101 in 46 payments from 14 companies in 2025. Trend: 2023 $397 · 2024 $1,028 · 2025 $1,101
Food & beverage: $1,101
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 8 | $217 |
| ABBVIE INC. | 9 | $182 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $141 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $91 |
| Regeneron Healthcare Solutions, Inc. | 4 | $90 |
| Aimmune Therapeutics, Inc. | 3 | $78 |
| GENZYME CORPORATION | 2 | $58 |
| Lilly USA, LLC | 2 | $57 |
| Janssen Biotech, Inc. | 2 | $49 |
| Phathom Pharmaceuticals, Inc. | 2 | $36 |
Products named: REZDIFFRA, DUPIXENT, ENTYVIO, RINVOQ, XIFAXAN, ZENPEP, SKYRIZI, OMVOH.
Industry payments across WA — which companies pay providers there.
